Ferritin-to-Albumin Ratio Predicts Mortality Risk in Non-COVID-19 Pneumonia Patients: Study

The study’s authors emphasize the potential for FAR to be used as a simple, cost-effective tool in critical care settings. Because ferritin and albumin levels are already part of standard laboratory testing, clinicians could easily calculate FAR without requiring additional procedures or expenses. This could aid in early risk stratification, helping identify patients who may need closer monitoring or more aggressive treatment. Although further prospective studies are needed to validate the findings, the evidence suggests that FAR could complement existing severity scores and guide personalized care strategies for patients with pneumonia. By bridging inflammation and nutrition into a single measure, FAR may become a valuable addition to the clinician’s toolkit for improving outcomes in serious respiratory infections.

Reference: Feng, J., Zhao, T., Huang, Y., Lai, S., & Chen, G. (2025). Ferritin-to-Albumin Ratio Predicts Short-Term Mortality in Critically Ill Patients with Non-COVID-19 Pneumonia: A Retrospective Cohort Study from MIMIC-IV database. Respiratory Medicine. https://doi.org/10.1016/j.rmed.2025.108361

Keywords: ferritin-to-albumin ratio, non-COVID-19 pneumonia, inflammation, nutrition, mortality risk, intensive care, prognostic biomarker.